A user's progress with hair loss treatments, including minoxidil, microneedling, nizoral 2%, finasteride 0.5mg/day and 0.5mg/ml per day in minoxidil, as well as RU58841 purchased from Anagen Inc., which allowed the user to go outside without a hat or cap for two years.
The user experienced side effects from finasteride and is considering switching to dutasteride, while also using pyrilutamide to protect hair follicles. They are seeking advice on whether to add RU58841 to their regimen.
User plans to switch from oral to .005% topical finasteride, using a solvent from minoxidilmax and later Essengen-F. They will monitor DHT levels and seek advice on solvents and sleep caps.
The conversation is about a user planning to undergo a hair transplant and seeking information on clinics that perform Verteporfin treatment. A user suggests Dr. Barghouthi might offer this service.
A user is treating hair loss with Dutasteride, Minoxidil, RU58841, Derminator 2, Vitamin D, Biotin, and Zinc. After 6 months, there's no significant visual improvement, but the user feels less insecure about Retrograde Alopecia.
Using hair loss treatments such as Minoxidil and Finasteride to combat male pattern baldness, with the poster expressing hope in regaining confidence and security. Replies offer advice, anecdotes, and support for the user's efforts.
A user experienced hair loss and side effects from oral finasteride, leading them to consider switching to topical finasteride to reduce side effects while maintaining hair. Another user suggested trying dutasteride under medical supervision, noting individual differences in side effects.
Topical finasteride that doesn't penetrate the skin could potentially treat hair loss without side effects. Current challenges include finding a formulation that remains on the scalp without increasing blood levels.
People are hopeful about future hair loss treatments like PP405, GT20029, and VDPHL01, while some are currently using finasteride and minoxidil. There is skepticism about the effectiveness of new treatments, and some advise against hair transplants until more promising drugs are available.